TNF Blockers

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

Amjeveta (adalimumab-atto) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Amjeveta is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Amjeveta may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Enbrel (etanercept) is used to treat rheumatoid, psoriatic, and juvenile idiopathic arthritis, ankylosing spondylitis, and plaque psoriasis. Enbrel will also be available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. The currently approved biosimliars for enbrel are eticovo (etanercept-ykro) and erelzi (etanercept-szzs). Enbrel may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Adalimumab-ryvk (Simlandi) is part of the TNF Blockers class and treats Plaque Psoriasis, Juvenile Idiopathic Arthritis, Uveitis and other conditions. TNF blockers are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis and ulcerative colitis. They work by reducing inflammation throughout the body, including in the joints, skin, eyes, and intestines. Adalimumab-ryvk (Simlandi) is only available as a brand name drug.

Abrilada (adalimumab-afzb) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, hidradenitis suppurativa, uveitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Abrilada is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Abrilada is a TNF blocker which works by reducing inflammation throughout the body. The most common form of Abrilada is a carton of two 40mg/0.8mg syringes. It is also available as a vial. It is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower.

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

Hadlima (adalimumab-bwwd) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, hidradenitis suppurativa, uveitis and ulcerative colitis. Hadlima is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Hadlima may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

ADALIMUMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

Yusimry (adalimumab-aqvh) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, hidradenitis suppurativa, uveitis and ulcerative colitis. Yusimry is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Yusimry may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Hyrimoz (adalimumab-adaz) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Hyrimoz is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Hyrimoz may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Yuflyma (adalimumab-aaty) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease and ulcerative colitis. Yuflyma is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Yuflyma may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Hulio (adalimumab-fkjp) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, hidradenitis suppurativa, uveitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Hulio is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Hulio may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Cyltezo (adalimumab-adbm) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, hidradenitis suppurativa, uveitis and ulcerative colitis. Cyltezo is an interchangeable biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Cyltezo may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

GOLIMUMAB treats autoimmune conditions, such as arthritis and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

INFLIXIMAB treats autoimmune conditions, such as psoriasis, arthritis, Crohn's disease, and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

Humira (adalimumab) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease and ulcerative colitis. Humira is also available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Humira may be covered by your Medicare or insurance plan.

GOLIMUMAB treats autoimmune conditions, such as arthritis and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody.

Idacio (adalimumab-aacf) is used to treat rheumatoid, psoriatic and juvenille idiopathic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn's disease and ulcerative colitis. Idacio is a biosimilar for humira (adalimumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Idacio may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

Avsola (infliximab-axxq) is used to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Avsola is a biosimilar for remicade (infliximab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Avsola may be covered by your Medicare or insurance plan.

Cimzia (certolizumab pegol) is used to treat Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis and plaque psoriasis. There is currently no generic alternative. It may be covered by your Medicare or insurance plan.

Inflectra (Infliximab-dyyb) is used to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Inflectra is a biosimilar for remicade (infliximab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Inflectra may be covered by your Medicare or insurance plan.